Initiate the literature search to prioritise TAM targets for internal development and confirm the therapeutic value of anti-SIGLEC1 antibodies.

  • Pollard, Jeffrey (Principal Investigator)
  • Cassetta, Luca (Co-investigator)

Project Details

StatusFinished
Effective start/end date26/02/20 → 25/02/22

Funding

  • UK industry, commerce and public corporations: £733,740.00